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PRELIMINARYSTUDIES IDENTIFYING
AND QUANTIFYING TRACE METAL IMPURITIES
IN ILLICIT ECSTASY TABLETS USING ATOMIC
SPECTROMETRY TECHNIQUES
Ruth J. H. WADDELL, David LITTLEJOHN, Niamh NIC DAÉID
Forensic Science Unit, University of Strathclyde, Glasgow, United Kingdom
ABSTRACT: This paper illustrates some preliminary investigations into using
ICP-MS in combination with ET-AAS in the analysis of Ecstasy tablets. Results indi-
cate that a combination of both techniques can show discriminating power between
seizures. Descriptions of the modifications made to optimise the ET-AAS system are
described.
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INTRODUCTION
Ecstasy (3,4-methylenedioxymethylamphetamine or MDMA) is a mem-
ber of the amphetamine drug class and, in the UK, is controlled under the
Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations 1985. Ille-
gally synthesised in clandestine laboratories, Ecstasy is predominantly pro-
duced in tablet form, often with a distinctive motif. Profiling illicit drug sei-
zures is essential in order to quantify the active constituent present and to
gather drug intelligence. Quantification has ramifications in subsequent
criminal proceedings while gathering intelligence may identify dealer-user
networks. Currently, physical and chemical profiling relies on:
– physical description,
– presumptive tests,
– TLC;
– instrumental methods, generally chosen from HPLC, GC-FID, GC/MS
or FT-IR.
Various synthetic routes are known for Ecstasy production, the chosen
route often indicating the geographical origin of the seizure. In addition,
route specific organic impurities are formed, which are identified by chro-
matographic methods, normally GCFID or GC/MS. The resulting chromato-
grams are known as “impurity profiles”. Seizures with the same organic im-
purities may tentatively be linked to a common synthetic route although not
necessarily to a common laboratory. However, where the same impurities
are present in similar concentrations, the seizures may have originated from
acommon batch.
Elemental analysis of illicit seizures has the potential to augment or-
ganic impurity profiling, with the possibility of providing evidence to sup-
port both common route and batch links. Trace metals may be present in the
seizure due to reducing agents/catalysts used during synthesis, leaching
from vessels into the reaction mixture, contamination from diluents used to
“bulk out” the tablets or external contamination, resulting from packaging
and handling. In theory, seizures synthesised by the same route will contain
common trace metals, which should be present in similar concentrations if
the seizures originate from common laboratories. Potentially, such links
may be enhanced where similar ratios of drug-bound versus unbound metal
are determined.
In the literature, trace metal analysis of illicit heroin [3] and met-
amphetamine [2] seizures has been reported, using inductively coupled
plasma-mass spectrometry (ICP/MS) and flame atomic absorption spec-
trometry (FAAS) for classification purposes. Little has been published for
similar work involving Ecstasy seizures.
AIMS AND OBJECTIVES
The aim of this work is to investigate the possibility of initially detecting
trace metal elements in illicit Ecstasy seizures by ICP/MS and quantifying
selected metals using electrothermal atomic absorption spectrometry
(ET-AAS). The initial objectives are:
1. To develop a reproducible method of sample preparation.
2. To rapidly screen illicit Ecstasy seizures using ICP/MS to identify ele-
ments of potential use in classification.
3. To obtain reproducible detection of Pb in illicit Ecstasy seizures with
minimal interference effects, using ET-AAS.
EXPERIMENTAL METHODS
Sample preparation: Ecstasy tablets were powdered and digested
(150 mg) in 10% HNO3 , using a CEM 2000 microwave and following the di-
gestion programme outlined in Table I. Digests were diluted to give a final
concentration of 1.5 mg tablet/ml in 1% HNO3.
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A Sciex Elan 6000 ICP/MS instrument, set to the default parameters,
was used to analyse the Ecstasy tablet digests. A UNICAM 929 ET-AAS
Spectrometerwas used to detect Pb in the tablet digests.
TABLE I. MICROWAVE DIGESTION PROGRAMME
Stage 1 2 3
Power [%] 60 60 60
Pressure [psi] 40 180 150
Time [min] 10 10 10
Time at pressure [min] 5 5 5
Using matrix-matched standards, linearity over the concentration range
0 to 30 ng Pb/ml was established and the regression equation and co-efficient
of the calibration graph were determined. Digested tablets were analysed in
triplicate and quantified, expressing the Pb concentration determined as mg
Pb/g tablet in the original digest. In addition, a L’Vov platform was inserted
into the furnace tube to investigate the benefits of platform atomisation over
tube wall atomisation. The optimised furnace temperature programme for
platform atomisation is presented in Table II.
TABLE II. OPTIMISED FURNACE TEMPERATURE PROGRAMME FOR PLATFORM
ATOMISATION
Stage Temp [°C] Time [s] Ramp [°C/s] Gas type
Gas flow
[ml/min]
Dry 1 80 20 10 Ar 200
Dry 2 150 40 2 Ar 200
Pyrolysis 700 30 50 Ar 200
Atomisation 2000 3 > 2000 Ar 0
Clean 2600 2 >2000 Ar 200
RESULTS AND DISCUSSION
Analysis by ICP/MS indicated significantly higher concentrations of Pb,
Cu and Zn in the tablet digests compared with blank digests, as illustrated
in Figure 1.
Pb was initially chosen for quantification by ET-AAS, due to its apparent
ease of analysis. Using tube wall atomisation, there was poor recovery of Pb,
especially at low concentrations (10 ng Pb/ml). However, with a L’Vov plat-
form in place, improvements in recovery of up to 20% were obtained. For
4 different seizures, the calculated mean Pb concentrations ranged from
1.8 mg Pb/g tablet to 2.9 mg Pb/g tablet. Yet, despite platform atomisation,
background absorbance was observed on the sample absorption profiles
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Fig. 1. Concentration of selected elements detected by ICP/MS.
Fig. 2a. 10 ng Pb/ml standard solution.
Fig. 2a. Sample NND 143 (1.5 mg/ml).
(Figure 2), indicating that the interference effect had not been fully elimi-
nated. This was further supported with a spike and recovery experiment
where Pb recoveries were found to be outwith the acceptable 95%–105%
range[1].
CONCLUSIONS & FURTHER WORK
ICP/MS analysis proved to be effective in rapidly screening tablet digests
to identify elements of potential use in chemical profiling. Additionally,
ET-AAS analysis was successful in detecting low levels of Pb in acid digested
Ecstasy tablets. However, in spite of platform atomisation, an interference
effect continued to be present, as indicated by Pb recoveries which were
outwith the acceptable 95%–105% range. The work has illustrated the po-
tential benefits of trace metal analysis to enhance conventional profiling
methods although the problem of interference effects remains to be fully ad-
dressed.
In terms of further work, numerous possibilities are available and, per-
haps those of most interest include the analysis of a number of large Ecstasy
seizures (which are known to be different from HPLC and GC/MS analysis)
by ICP-MS to assess differences in the metals present and concentrations of
each. To improve Pb recovery at low concentrations by ET-AAS and to inves-
tigate the use of alternative matrix modifiers such as palladium are also on
interest. Quantification of the Pb concentration in a number of large Ecstasy
seizures and, in combination with HPLC and GC-MS data, attempting to
link seizures and expanding the ET-AAS technique for the detection of other
trace metals indicated as potentially discriminating by ICP/MS analysis are
being undertaken.
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